Javascript must be enabled to continue!
Environment-Responsive Dopamine Nanoplatform for Tumor Synergistic Therapy
View through CrossRef
Abstract
Nanoparticle-based photothermal therapy (PTT) has emerged as a promising approach in tumor treatment due to its high selectivity and low invasiveness. However, the penetration of near-infrared light (NIR) is limited, leading it fails to induce damage to the deep-seated tumor cells within the tumor tissue. Additionally, inefficient uptake of photothermal nanoparticles by tumor cells results in suboptimal outcomes for PTT. Based on the above-mentioned issues, this study utilized the adhesive properties of photothermal material, polydopamine (PDA), which can successfully load the photosensitizer indocyanine green (ICG) and chemotherapeutic drug doxorubicin (DOX) to achieve combined photothermal and chemotherapy treatment (PDA/DOX&ICG), aiming to compensate for the poor penetration of NIR in tumor tissues and the photothermal conversion performance of PDA. For the purpose of extending the blood circulation time of PDA/DOX&ICG nanoparticles, evading clearance by the body immune system and achieving targeted delivery to tumor tissues, a protective envelopment was created using erythrocyte membranes modified with folate acid (FA-EM). After reaching the tumor tissue, the obtained FA-EM@PDA/DOX&ICG nanoparticles can specific bind with folate acid receptors on the surface of tumor cells. This interaction facilitates improved uptake by tumor cells leading to the subsequent release of loaded DOX and ICG in response to the unique tumor microenvironment. DOX penetration ability can effectively compensate the limitation of NIR penetration at the tumor tissue. While ICG, as a typical photosensitizer, significantly enhances the photothermal conversion performance of FA-EM@PDA/DOX&ICG nanoparticles, thereby inducing tumor cells damage. In vitro and in vivo experimental results demonstrated that the coordinated NIR treatment with FA-EM@PDA/DOX&ICG not only effectively inhibits tumor growth but also exhibits superior biocompatibility, effectively mitigating DOX-induced tissue damage.
Title: Environment-Responsive Dopamine Nanoplatform for Tumor Synergistic Therapy
Description:
Abstract
Nanoparticle-based photothermal therapy (PTT) has emerged as a promising approach in tumor treatment due to its high selectivity and low invasiveness.
However, the penetration of near-infrared light (NIR) is limited, leading it fails to induce damage to the deep-seated tumor cells within the tumor tissue.
Additionally, inefficient uptake of photothermal nanoparticles by tumor cells results in suboptimal outcomes for PTT.
Based on the above-mentioned issues, this study utilized the adhesive properties of photothermal material, polydopamine (PDA), which can successfully load the photosensitizer indocyanine green (ICG) and chemotherapeutic drug doxorubicin (DOX) to achieve combined photothermal and chemotherapy treatment (PDA/DOX&ICG), aiming to compensate for the poor penetration of NIR in tumor tissues and the photothermal conversion performance of PDA.
For the purpose of extending the blood circulation time of PDA/DOX&ICG nanoparticles, evading clearance by the body immune system and achieving targeted delivery to tumor tissues, a protective envelopment was created using erythrocyte membranes modified with folate acid (FA-EM).
After reaching the tumor tissue, the obtained FA-EM@PDA/DOX&ICG nanoparticles can specific bind with folate acid receptors on the surface of tumor cells.
This interaction facilitates improved uptake by tumor cells leading to the subsequent release of loaded DOX and ICG in response to the unique tumor microenvironment.
DOX penetration ability can effectively compensate the limitation of NIR penetration at the tumor tissue.
While ICG, as a typical photosensitizer, significantly enhances the photothermal conversion performance of FA-EM@PDA/DOX&ICG nanoparticles, thereby inducing tumor cells damage.
In vitro and in vivo experimental results demonstrated that the coordinated NIR treatment with FA-EM@PDA/DOX&ICG not only effectively inhibits tumor growth but also exhibits superior biocompatibility, effectively mitigating DOX-induced tissue damage.
Related Results
Exploring the in vivo subthreshold membrane activity of phasic firing in midbrain dopamine neurons
Exploring the in vivo subthreshold membrane activity of phasic firing in midbrain dopamine neurons
Dopamine is a key neurotransmitter that serves several essential functions in daily behaviors such as locomotion, motivation, stimulus coding, and learning. Disrupted dopamine circ...
Abstract 1856: Adaptation to dopamine impairs the anti-cancer effect of ONC201 and ONC206
Abstract 1856: Adaptation to dopamine impairs the anti-cancer effect of ONC201 and ONC206
Abstract
ONC201 (originally discovered as TRAIL-Inducing Compound #10 or TIC10) and analogue ONC206 have been found to induce an integrated stress response with sugg...
Pharmacokinetics of Dopamine in Healthy Male Subjects
Pharmacokinetics of Dopamine in Healthy Male Subjects
Background
Dopamine is an agonist of alpha, beta, and dopaminergic receptors with varying hemodynamic effects depending on the dose of drug being administered. The purp...
Chitosan-Catechol Modified Dopamine Sensor
Chitosan-Catechol Modified Dopamine Sensor
Dopamine is a neurotransmitter found in several deep structures of the brain. For example, in the ventral tegmental area (VTA) of the midbrain, in the substantia nigra pars compact...
Adaptor Protein-3 Produces Synaptic Vesicles that Release Phasic Dopamine
Adaptor Protein-3 Produces Synaptic Vesicles that Release Phasic Dopamine
AbstractThe burst firing of midbrain dopamine neurons releases a phasic dopamine signal that mediates reinforcement learning. At many synapses, however, high firing rates deplete s...
Mengendalikan Dopamine Detox
Mengendalikan Dopamine Detox
The purpose of this research is to find out and learn about "Dopamine Detox" from the "1 Day of Success" youtube channel entitled "Control Yourself From All Addictions". In this st...
The Dopamine Receptors
The Dopamine Receptors
Abstract
Dopamine receptors have a prominent place in our understanding of brain function. Drugs blocking dopamine receptors are used as antipsy...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...

